Development and characterization of immobilized human organic anion transporter-based liquid chromatographic stationary phase: hOAT1 and hOAT2

被引:18
作者
Kimura, T.
Perry, J.
Anzai, N.
Pritchard, J. B.
Moaddel, R.
机构
[1] NIA, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA
[2] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA
[3] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 859卷 / 02期
关键词
hOAT1; hOAT2; drug transporters; affinity chromatography;
D O I
10.1016/j.jchromb.2007.09.039
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This paper reports the development of liquid chromatographic columns containing immobilized organic anion transporters (hOAT1 and hOAT2). Cellular membrane fragments from MDCK cells expressing hOAT1 and S2 cells expressing hOAT2 were immobilized on the surface of the immobilized artificial membrane (IAM) liquid chromatographic stationary phase. The resulting stationary phases were characterized by frontal affinity chromatography, using the marker ligand [H-3]-adefovir for the hOAT1 and [C-14]-p-aminohippurate for the hOAT2 in the presence of multiple displacers. The determined binding affinities (K-d) for eight OAT1 ligands and eight OAT2 ligands were correlated with literature values and a statistically significant correlation was obtained for both the hOAT1 and hOAT2 columns: r(2) = 0.688 (p < 0.05) and r(2) = 0.9967 (p < 0.0001), respectively. The results indicate that the OAT1 and OAT2 have been successfully immobilized with retention of their binding activity. The use of these columns to identify ligands to the respective transporters will be presented. Published by Elsevier B.V.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 28 条
[1]  
ANZAI N, 1999, J PHARM SCI, V276, pF122
[2]  
Apiwattanakul N, 1999, MOL PHARMACOL, V55, P847
[3]   Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells [J].
Aslamkhan, AG ;
Han, YH ;
Yang, XP ;
Zalups, RK ;
Pritchard, JB .
MOLECULAR PHARMACOLOGY, 2003, 63 (03) :590-596
[4]   Human organic anion transporters mediate the transport of tetracycline [J].
Babu, E ;
Takeda, M ;
Narikawa, S ;
Kobayashi, Y ;
Yamamoto, T ;
Cha, SH ;
Sekine, T ;
Sakthisekaran, D ;
Endou, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 (01) :69-76
[5]   Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta [J].
Cha, SH ;
Sekine, T ;
Kusuhara, H ;
Yu, E ;
Kim, JY ;
Kim, DK ;
Sugiyama, Y ;
Kanai, Y ;
Endou, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (06) :4507-4512
[6]   Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney [J].
Cha, SH ;
Sekine, T ;
Fukushima, J ;
Kanai, Y ;
Kobayashi, Y ;
Goya, T ;
Endou, H .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1277-1286
[7]   Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1 [J].
Cihlar, T ;
Ho, ES .
ANALYTICAL BIOCHEMISTRY, 2000, 283 (01) :49-55
[8]   The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1 [J].
Cihlar, T ;
Lin, DC ;
Pritchard, JB ;
Fuller, MD ;
Mendel, DB ;
Sweet, DH .
MOLECULAR PHARMACOLOGY, 1999, 56 (03) :570-580
[9]  
Dresser MJ, 2001, J PHARM SCI, V90, P397, DOI 10.1002/1520-6017(200104)90:4<397::AID-JPS1000>3.3.CO
[10]  
2-4